This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +22.98% per year. These returns cover a period from January 1, 1988 through April 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Azure Aids MSFT's Q3 Beat: Should AI-Focused Investors Buy the Stock?
by Vasundhara Sawalka
Microsoft's Q3 shines with Azure's 33% growth and AI leadership. Strong financials and strategic vision make MSFT stock a compelling buy for investors in 2025.
AMZNPositive Net Change MSFTPositive Net Change NVDAPositive Net Change GOOGLNegative Net Change
artificial-intelligence cloud-computing tech-stocks
Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?
by Urmimala Biswas
Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
earnings-outlook earnings-report healthcare medical medical-devices
ASML vs. TSM: Which Semiconductor Stock is the Smarter Buy?
by Anirudha Bhagat
ASML Holding and Taiwan Semiconductor Manufacturing power the chip industry, but ASML's EUV monopoly and strong outlook give it the investment edge.
ASMLPositive Net Change TSMPositive Net Change
artificial-intelligence computers semiconductor tech-stocks
MarketAxess Q1 Earnings Beat on Emerging Markets Strength
by Zacks Equity Research
MKTX returns $38.1 million to shareholders in the first quarter via share buybacks.
MKTXNegative Net Change HRTGPositive Net Change ATLCNegative Net Change ROOTPositive Net Change
earnings finance
Canadian Pacific Kansas City Q1 Earnings Match Estimates, Up Y/Y
by Zacks Equity Research
CP's first-quarter 2025 earnings and revenues improve year over year.
DALPositive Net Change UALPositive Net Change CPPositive Net Change LSTRPositive Net Change
earnings transportation
UBER Q1 Earnings Surpass Estimates, Improve Year Over Year
by Zacks Equity Research
UBER's first-quarter 2025 earnings and revenues improve year over year.
BIDUNegative Net Change LYFTNegative Net Change UBERNegative Net Change
earnings ride-hailing
Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y
by Zacks Equity Research
PRGO reports mixed first-quarter 2025 results. The top line declines, largely due to the loss of sales stemming from exited businesses and product lines.
PRGOPositive Net Change PBYIPositive Net Change NTLAPositive Net Change ELEVNegative Net Change
earnings medical
Allot to Report Q1 Earnings: What's in the Offing for the Stock?
by Zacks Equity Research
ALLT's revenues in the first quarter of 2025 are anticipated to have decreased compared to the prior year, with the net loss potentially widening.
EFXPositive Net Change ALLTNegative Net Change FINegative Net Change
business-services earnings
Bandwidth Q1 Earnings Beat Estimates on Solid Revenue Growth
by Zacks Equity Research
BAND reports a top-line growth year over year, driven by healthy demand for its cloud communication services and disciplined operating execution.
AKAMNegative Net Change HUBSPositive Net Change BANDPositive Net Change PINSPositive Net Change
tech-stocks
Cytokinetics Q1 Earnings Beat, Aficamten Target Action Date Extended
by Zacks Equity Research
CYTK reports narrower-than-expected Q1 loss. However, the target action date for aficamten in obstructive HCM has been extended by the FDA to provide time for reviewing a REMS submission made at the agency's request.
SNYNegative Net Change BAYRYNegative Net Change CYTKNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
MPLX Q1 Earnings Beat on Higher Throughputs, Revenues Increase Y/Y
by Zacks Equity Research
MPLX Q1 earnings gain on higher pipeline throughputs and a rise in gathered and processed volumes from the Utica and Permian Basins.
EQTPositive Net Change MPLXNegative Net Change GLPEYNegative Net Change AROCNegative Net Change
earnings energy oil-energy
Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses
by Zacks Equity Research
SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset the sales decline.
PINCPositive Net Change HQYPositive Net Change PGNYPositive Net Change SOLVPositive Net Change
medical medical-devices
Denali Q1 Loss Wider Than Expected, Hunter Syndrome Drug in Focus
by Zacks Equity Research
DNLI reports a wider-than-expected loss for the first quarter of 2025. Denali submits a BLA for tividenofusp alfa under the FDA???s accelerated approval pathway based on data from the phase I/II study in participants with Hunter syndrome.
SNYNegative Net Change BIIBPositive Net Change DNLIPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised
by Zacks Equity Research
COR's second-quarter fiscal 2025 results showcase a strong segmental performance. The company's earnings guidance for fiscal 2025 looks encouraging.
MASINegative Net Change CVSPositive Net Change CORPositive Net Change AXGNNegative Net Change
earnings medical medical-devices
UBS Collaborates With General Atlantic, Expands Into Private Credit
by Zacks Equity Research
UBS Group teams up with General Atlantic to expand investing clients' and borrowers' access to a broader set of direct lending and other credit products.
JPMPositive Net Change CPositive Net Change UBSPositive Net Change APOPositive Net Change
finance
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
by Zacks Equity Research
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.
BSXPositive Net Change CVSPositive Net Change ITGRPositive Net Change AVNSNegative Net Change
earnings medical medical-devices
BG Q1 Earnings Beat, Revenues Down Y/Y on Weak Results Across Segments
by Zacks Equity Research
Bunge Global reports a 41% decline in earnings in Q1. The company's 2025 earnings per share guidance of $7.75 indicates a 15.7% year-over-year decline.
ANDENegative Net Change ADMNegative Net Change BGNegative Net Change HYFMPositive Net Change
agriculture basic-materials earnings
Intel Excels in Stringent AI Benchmark: Should You Buy the Stock?
by Aritra Chatterjee
Despite solid traction in the AI PC market and portfolio expansion, INTC's growth prospects are affected by stiff competition, high debt levels and geopolitical volatility.
INTCPositive Net Change AMDPositive Net Change NVDAPositive Net Change
artificial-intelligence semiconductor tech-stocks
Gildan Activewear Stock Gains 44.8% in a Year: Time to Hold or Avoid?
by Zacks Equity Research
GIL continues to benefit from its successful execution of strategies, including the Sustainable Growth strategy, and innovations.
CROXPositive Net Change GIIIPositive Net Change GILNegative Net Change DLTHPositive Net Change
consumer-discretionary
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
by Zacks Equity Research
WAT's first-quarter 2025 results reflect strong growth in the instruments and chemical segments, coupled with strong momentum in the industrial and pharma sectors.
WATPositive Net Change AGENNegative Net Change ANIPPositive Net Change ACXPPositive Net Change
earnings medical
Terex Q1 Earnings & Revenues Beat Estimates, Decline Y/Y on Low Volumes
by Zacks Equity Research
TEX witnesses year-over-year decline in Q1 earnings due to low volumes. Its guidance for 2025 earnings per share of $4.70 - $5.10 suggests a 20% decline at the midpoint.
MTWPositive Net Change CATNegative Net Change TEXNegative Net Change HYNegative Net Change
construction earnings industrial-products
AMSF Stock Down 6% Despite Q1 Earnings Beat on New Business Growth
by Zacks Equity Research
AMERISAFE's Q1 results reflect premium growth and fee income surge, partly offset by weaker underwriting profits and rising underwriting expenses.
RLINegative Net Change AMSFNegative Net Change ACGLNegative Net Change KNSLPositive Net Change
earnings insurance
Ralph Lauren Stock Gains More Than 44% in a Year: Time to Buy or Hold?
by Zacks Equity Research
RL gains from expanding its lifestyle brands globally and digital efforts. Its retail and wholesale channels are performing well.
RCLPositive Net Change RLPositive Net Change GILNegative Net Change DLTHPositive Net Change
consumer-discretionary
FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.
BSXPositive Net Change CVSPositive Net Change FMSPositive Net Change ITGRPositive Net Change
earnings medical medical-devices
Trimble Earnings Surpass Estimates in Q1, Revenues Decline Y/Y
by Zacks Equity Research
Trimble's Q1 results reveal slowing growth in both the Product, and Subscription and services segments, highlighting near-term headwinds.
TRMBPositive Net Change CCKNegative Net Change UNFNegative Net Change CSTMNegative Net Change
earnings industrial-products